Sunday, February 12, 2012
 
 
  Home arrow Birth Control arrow Birth Control Archive arrow Migraine - Oral Contraceptive Link (N, 06)
Main Menu
Home
About Us
Current Headlines
Abortion
Abstinence
Birth Control
End of Life / Euthanasia
Medical Research
Medical Students
Population
Position Statements
Pregnancy/Development
STDs
Stem Cells & Cloning
Contact Us
Web Links
Site Index
Resources
Related Items
Translator
Quotes to Note

Every 38 seconds a woman lays her body down for an abortion, sacrificing her child because she lacks practical resources and emotional support.

About two-thirds of women who have abortions feel pressured to do so. They rarely have the critical information that abortion can dramatically increase their risk of breast cancer.

Even 1 abortion can increase a woman's chance of breast cancer by 90%.

Teens who have an abortion in their second trimester, have a history of breast cancer in their family, and do not have children later, have an 800% higher risk of breast cancer.

Women have the Right to Know about the LINK between abortion and breast cancer.

Women deserve full medical disclosure.

Women can handle it.

Women deserve better... than abortion.

["Abortion-Breast Cancer Link," Angela Lanfranchi, M.D. and Joel Brind, Ph.D.; Feminists for Life of America, 9/04]

 
Migraine - Oral Contraceptive Link (N, 06) PDF Print E-mail

STUDY FINDS ORAL CONTRACEPTIVE-MIGRAINE LINK

Women who take oral contraceptives [OCs] have increased chances of suffering from both migraines and non-migraine headaches, a large new population-based study shows.

Some women have migraines during menstruation, when levels of estrogen drop, said Dr. Karen Aegidius [Norwegian National Headache Center, Trondheim, the study‘s lead author]. These women also are more likely to have migraines while taking OCs; these pills can boost estrogen levels up to four-fold above normal, resulting in a particularly steep estrogen drop-off with menstruation.

Aegidius and her colleagues studied data from 13,944 women included in the Nord-Trondelag Health Study in Norway who responded to questions on both OC use and headaches.

Migraines were 40 percent more common among women taking OCs, the researchers report in the medical journal Neurology, and non-migraine headaches were 20 percent more common. However, the team could find no link between the amount of hormones contained in the pills and headache risk.

Physicians whose patients suffer headaches while on the pill could prescribe an estrogen patch to be used 2 to 3 days before menstruation, Aegidius suggested, so that estrogen levels wouldn‘t drop so steeply.

Another possibility, she added, is for women to stay on estrogen for 3 consecutive months, so they experience headaches just 4 times a year rather than every month.


Finally, she pointed out that the fall in estrogen with Mircette, an OC available in the US but not Europe, is gradual rather than immediate, which could reduce headache risk.

[Neurology, 14Feb06; posted 4 March06, Anne Harding 2Mar06 New York, Reuters Health;  N Valko RN, 5Mar06; http://www.newsone.ca/piercelandherald/stories/index.php?action=fullnews&id=152680]

 
< Prev   Next >


Go to top of page  Home | About Us | Current Headlines | Abortion | Abstinence | Birth Control | End of Life / Euthanasia | Medical Research | Medical Students | Population | Position Statements | Pregnancy/Development | STDs | Stem Cells & Cloning | Contact Us | Web Links | Site Index | Resources |
 
PhysiciansForLife.org Copyright (C) 2004-2012 All Rights Reserved